In this regard, assays of phosphorylated Tau at threonine 217 (pTau-217) and threonine 181 (pTau-181), developed by Lilly and Simoa®®, are being utilized as tauopathy blood markers, respectively. The gene discussed is MAPT; the disease is tauopathy.